Lumos Pharma (LUMO)
(Delayed Data from NSDQ)
$2.54 USD
-0.09 (-3.42%)
Updated May 17, 2024 04:00 PM ET
After-Market: $2.53 -0.01 (-0.39%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.44 | 381.68% |
Earnings Summary
For their last quarter, Lumos Pharma (LUMO) reported earnings of -$1.29 per share, missing the Zacks Consensus Estimate of -$1.21 per share. This reflects a negative earnings surprise of 6.61%. Look out for LUMO's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.44 per share, reflecting a year-over-year increase of 59.63%.
Earnings History
Price & Consensus
Zacks News for LUMO
Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates
LUMO: What are Zacks experts saying now?
Zacks Private Portfolio Services